Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature
- PMID: 26342205
- PMCID: PMC4672735
- DOI: 10.1016/j.clineuro.2015.08.011
Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature
Abstract
Objective: Chordoid gliomas (CG) are rare neoplasms which frequently arise within the third ventricle. Surgery remains the mainstay treatment for CG. The present study comprehensively reviews all reported cases of CG within the literature in order to identify risk factors for surgical complications and tumor recurrence.
Methods: A comprehensive search on MEDLINE (OVID and PubMed), Scopus, Embase, and Web of Science was conducted following PRISMA guidelines to identify all reported cases of CG.
Results: A total of 81 patients met the study criteria which comprised of 33 males and 48 females. Median age at diagnosis was 48 years with a range from 5 to 72 years, and mean tumor size was 3.1cm. Biopsy, subtotal resection (STR), and gross total resection (GTR) were achieved in 8, 34, and 33 patients, respectively, with six cases not reporting extent of resection (EOR). Thirteen patients underwent adjuvant radiotherapy. Postoperative complications were noted in 30 cases (37%), with new onset diabetes insipidus being the most common. Postoperative morbidity was not associated with age, tumor size, or extent of resection. A trans-lamina terminalis approach demonstrated a strong trend towards decreased overall rates of postoperative morbidity compared to other approaches (p=0.051). GTR was associated with improved progression-free survival (PFS; p=0.028), while adjuvant radiotherapy, age, tumor size and proliferative index were not predictive of patient outcomes.
Conclusion: GTR should be the primary goal for the management of CG, as it is associated with improved rates of tumor control without an increased rate of postoperative complications. Surgical approach was a stronger predictor of complication rates than extent of resection. Morbidity remains high, and future studies to further elaborate on factors predictive of postoperative complications are critical.
Keywords: Chordoid; Diabetes insipidus; Glioma; Hypothalamic dysfunction; Radiosurgery.
Copyright © 2015 Elsevier B.V. All rights reserved.
Conflict of interest statement
There are no conflicts of interest to report.
Figures


Similar articles
-
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.J Neurooncol. 2025 Jan;171(2):279-298. doi: 10.1007/s11060-024-04861-6. Epub 2024 Nov 20. J Neurooncol. 2025. PMID: 39565459
-
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.J Neurooncol. 2022 Jan;156(2):233-256. doi: 10.1007/s11060-021-03901-9. Epub 2022 Jan 6. J Neurooncol. 2022. PMID: 34989964
-
The role of radiotherapy in intracranial hemangiopericytoma/solitary fibrous tumors : A Turkish Society for Radiation Oncology Central Nervous System Tumors Group Study (TROD 07-008).Strahlenther Onkol. 2025 Apr;201(4):431-437. doi: 10.1007/s00066-024-02338-z. Epub 2024 Dec 18. Strahlenther Onkol. 2025. PMID: 39692781
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28. Clin Orthop Relat Res. 2024. PMID: 38153106 Free PMC article.
Cited by
-
Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with IDH mutations and 1p/19q co-deletion.Oncotarget. 2017 Dec 18;8(70):115657-115666. doi: 10.18632/oncotarget.23371. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383189 Free PMC article.
-
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.Nat Commun. 2018 Feb 23;9(1):810. doi: 10.1038/s41467-018-02826-8. Nat Commun. 2018. PMID: 29476136 Free PMC article.
-
Analysis of the Factors Affecting the Prognosis of Glioma Patients.Open Med (Wars). 2019 Apr 4;14:331-335. doi: 10.1515/med-2019-0031. eCollection 2019. Open Med (Wars). 2019. PMID: 30997396 Free PMC article.
-
Pediatric diencephalic tumors: a constellation of entities and management modalities.Front Oncol. 2023 Jul 13;13:1180267. doi: 10.3389/fonc.2023.1180267. eCollection 2023. Front Oncol. 2023. PMID: 37519792 Free PMC article. Review.
-
Neurogenic fever in a patient with a chordoid glioma.BMJ Case Rep. 2016 Nov 17;2016:bcr2016218205. doi: 10.1136/bcr-2016-218205. BMJ Case Rep. 2016. PMID: 27856533 Free PMC article.
References
-
- Brat DJ, Scheithauer BW, Staugaitis SM, Cortez SC, Brecher K, Burger PC. Third ventricular chordoid glioma: A distinct clinicopathologic entity. J Neuropathol Exp Neurol. 1998;57:283–290. - PubMed
-
- Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. Journal of neuropathology and experimental neurology. 2002;61:215–225. - PubMed
-
- Tu A, Yeo T, Steinke D, Resch L, Mehta V. Chordoid glioma: Imaging pearls of a unique third ventricular tumor. Can J Neurol Sci. 2010;37:677–680. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous